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A B S T R A C T
The European Commission through its Directorates-General Joint Research Centre (DG JRC) and Health and
Food Safety (DG SANTE) is developing the European Platform on Rare Diseases Registration (EU RD Platform)
with the objective to set European-level standards for data collection and data sharing. In the field of rare
diseases the EU RD Platform will be a source of information on available rare disease patient data with large
transnational European coverage. One main function of the EU RD Platform is to enable interoperability for
the> 600 existing RD registries in Europe. The second function is to offer a sustainable solution for two large
European surveillance networks: European Surveillance of Congenital Anomalies (EUROCAT) and Surveillance
of Cerebral Palsy in Europe (SCPE).
EUROCAT is European network of population-based registries for the epidemiological surveillance of con-
genital anomalies. It covers about one third of the European birth population. The Central Database contains
about 800,000 cases with congenital anomalies among livebirths, stillbirths and terminations of pregnancy,
reported using the same standardised classification and coding. These high quality data enables epidemiological
surveillance of congenital anomalies, which includes estimating prevalence, prenatal diagnosis and perinatal
mortality rates and the detection of teratogenic exposures among others. The network also develops re-
commendations for primary prevention in the Rare Diseases National Plans for medicinal drugs, food/nutrition,
lifestyle, health services, and environmental pollution.
The network has received the European Commission's support since its inception. In order to offer a sus-
tainable solution for the continuation of EUROCAT activities, it was agreed that EUROCAT would become part of
the EU RD Platform. In 2015, the European level-coordination activities and the Central Database were trans-
ferred to the DG JRC, where the JRC-EUROCAT Central Registry is now located. This paper describes the
functioning of EUROCAT in the new setting, and gives an overview of the activities and the organisation of the
JRC-EUROCAT Central Registry.
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1. Introduction
The EUROCAT network was established in 1979, bringing together
professionals and researchers working in population-based congenital
anomaly registries across Europe.
The aims of the network are to collect population data and perform
epidemiological surveillance on congenital anomalies in Europe. Over
the years EUROCAT achieved standardisation of definitions, diagnoses
and terminology, principally by the development of the EUROCAT
guides and software for data management. Owing to the high level of
data harmonisation and interoperability, the EUROCAT methodology is
recognised worldwide and is used by many research groups. The data
are used also to facilitate early warning of new teratogenic exposures,
to evaluate the effectiveness of primary prevention and to assess the
impact of developments in prenatal screening.
These results of the network are relevant for informing European
public health authorities and may lead to public health actions. The
network acts as an information system and resource centre for health
professionals and the public regarding increasing or decreasing trends
or the occurrence of clusters indicating potential changes in exposures
to risk factors. It also provides a resource for collaborative research on
the causes and prevention of congenital anomalies.
The EUROCAT Central Registry was initially located in Belgium
(Catholic University of Louvain and later Scientific Institute for Public
Health), in 1999 moved to the London School of Hygiene and Tropical
Medicine, and from 2000 to 2014 was hosted by the University of Ulster
(Belfast, Northern Ireland) (Boyd et al., 2011). The central coordinating
activities of EUROCAT were from the beginning funded by grants re-
ceived from the EC. The organisation and activities of EUROCAT before
the transfer to the DG JRC in 2015 are described in Boyd et al. (2011).
The reason for the transfer of the Central Registry to DG JRC was to
provide a sustainable solution for the continuation of EUROCAT ac-
tivities, to secure the results of previous work and to keep the network
functioning (Martin et al., 2016). EUROCAT is now an integral part of
the European Platform on Rare Diseases Registration (EU RD Platform)
developed by the DG JRC in close collaboration with the EC's Directo-
rate for Health and Food Safety (DG SANTE).
2. The European Platform on Rare Diseases Registration
The development of the EU RD Platform is part of the im-
plementation of the EU policies in the field of rare diseases (European
Commission, 2014). The Platform's main objective is to cope with the
enormous fragmentation of RD patient data contained in hundreds of
patient registries across Europe by providing solutions for interoper-
ability between the RD data sources, for data collection and data
sharing. By addressing the above goals, the EU RD Platform will es-
sentially support knowledge generation on RD, allowing the identifi-
cation of patients with a given condition across Europe. This will help
reaching the required numbers to conduct epidemiological, clinical,
translational, pharmacological studies and research for advancing di-
agnosis and treatment for RD patients.
In particular, the EU RD Platform develops, provides and promotes
European-level standards for RD data collection and information ex-
change. The European RD Registry Infrastructure (ERDRI), developed
as a core component of the Platform, supports semantic interoperability
for RD data via the Central Metadata Repository, which is linked to the
European Directory of RD Registries. These tools make RD patient data
searchable and findable at EU level. This requires patient data to be
pseudonymised, a further function offered by ERDRI. Thus, the
Platform supports existing RD registries to become interoperable and
helps creation of new registries including the ones inside the European
Reference Networks (ERNs). These are 24 virtual networks involving
healthcare providers across Europe which concentrate knowledge and
resources for diagnosis and highly specialised treatment of rare and
complex diseases (European Reference Networks, 2018).
The EU RD Platform was also conceived to offer a sustainable so-
lution for two large European surveillance networks: EUROCAT and
Surveillance of Cerebral Palsy in Europe (SCPE). For both networks, the
European level-coordination activities and the central databases were
transferred to DG JRC. For these two particular networks the EU RD
Platform also functions as a data repository.
3. The JRC-EUROCAT Central Registry
The transfer of the EUROCAT Central Registry to DG JRC was an
intensive and complex process. This required completion of many legal
and technical procedures, including specifying the pathway for data
protection notification at the European level, and the creation of new
structures such as secure IT systems for data transfer and data man-
agement (Martin et al., 2016). The new JRC-EUROCAT Central Registry
is now fully operational and the routine surveillance of congenital
anomalies in Europe, developed by the network, continues effectively.
The role of the Central Registry is to maintain and further develop
the EUROCAT Central Database according to established coding
methodologies, ensure secure data transmission and data management
from all registries. Data management includes data checking, data
harmonization, quality assessment; the validated data included in the
Central Database are then used by the Central Registry to perform
routine statistical analysis for epidemiological surveillance. The Central
Registry also supports and participates in the coordinating activities of
the network, by maintaining regular contact with individual registries,
issuing a regular newsletter, preparation (content, logistics) and follow-
up of routinely planned meetings: Annual Registry Leader's meeting,
Scientific Symposia, Management Committee, Coding and Classification
Committee. The DG JRC also supports the work of the Registry Advisory
Service and EUROCAT Working Groups (WG) - Environment WG,
Genetic WG, Health Inequalities WG, Prevention WG, Prenatal WG,
Website WG - established to develop the scientific activities of the
network. The Central Registry also maintains the relationship with the
individual registries and gives advice for the implementation of
EUROCAT procedures. Moreover, the Central Registry has an important
role in the dissemination of the network's results through scientific
reports and publication of the relevant information on the JRC-
EUROCAT website.
3.1. Coordination of the EUROCAT network
Currently there are 39 active population-based registries from 23
countries (Fig. 1) covering more than 29% of European births (1.7
million) per year. All EUROCAT registries have a defined geographical
coverage: in some countries all births are covered by a registry and in
some countries less than 10% of that country's birth population are
covered by a registry (Table 1).
All EUROCAT registries use multiple sources of information to as-
certain cases in live births, late fetal deaths (≥20 weeks gestational
age), and terminations of pregnancy for fetal anomaly at any gesta-
tional age. Depending on the registry, the data sources include mater-
nity, neonatal, and paediatric records; fetal medicine, cytogenetic, pa-
thology, and medical genetics records; specialist services including
paediatric cardiology; and hospital discharge and child health records.
The information collected by the registries is summarised in Table S1
(Supplementary Information), while the more detailed registry de-
scriptions can be found on the EUROCAT website (Complete list of
EUROCAT members, 2018).
In addition to full and associate members, there are six affiliate
member registries (Bulgaria, Pleven; Denmark, Greenland; Latvia,
Moldova, Slovenia; Spain, Navarra) who do not transmit data but
participate in meetings and projects. These are registries with an active
interest in congenital anomaly surveillance which do not fulfil the re-
quirements for full or associate memberships, but are still working to-
wards the requirements. It is important to mention that the network is
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also expanding and 14 new registries from Italy, the UK, Slovakia,
Lithuania and Iceland are in the process of becoming EUROCAT
members. Information about the EUROCAT membership criteria and
the process of how to become a member can be obtained from the
EUROCAT website (EUROCAT Membership Criteria, 2018).
3.2. The EUROCAT Central Database
The EUROCAT Central Database contains over 800,000 cases of
congenital anomalies, and is an invaluable collection of data used for
routine surveillance and research. Data are collected and coded ac-
cording to EUROCAT standards, using validated international classifi-
cation systems where possible, which are defined in the EUROCAT
Guide 1.4 (EUROCAT Guide 1.4, 2016). A standard data set of 95 coded
variables (33 core variables) includes general information about the
baby and mother, the diagnosis of malformations (ICD10 codes, pre-
natal diagnosis, genetic test and karyotype, gestational age at dis-
covery), exposure of the mother, family history and socio-demographic
variables.
The Central Database is regularly updated. Data are transmitted by
individual registries to the JRC-EUROCAT Central Registry twice a
year, in February and October, via a secure web-portal. The data that
are sent are usually cases that have been born two years before (e.g. in
2018 the registries are reporting cases born in 2016).
A EUROCAT Data Management Programme (EDMP) was developed
by the network to obtain high quality data for surveillance in a timely
manner (EDMP User Guide, 2018). The system ensures that all data are
coded according to agreed specifications and verifies each case before
submission achieving an “a priori” data harmonization. The EDMP
software is provided to all Member registries, which are requested to
use it for checking their data and formatting prior to transmitting data
to the Central Registry. In addition, the ability to create different types
of reports/data analysis at both the local level and by the Central
Registry allow results to be shared with and approved by the registries
before being disseminated on the network's website. The EDMP soft-
ware is regularly updated, depending on the needs (e.g. implementation
of new checks, addition of new variables). The most recent update was
carried out in January 2018.
A similar programme called EUROCAT Central Database (ECD) was
developed to be used only by the Central Registry with the aim to
manage in a standardized manner data from all registries, to perform
the routine statistical monitoring with standardized and validated
Fig. 1. Map of the active EUROCAT registries (full and associate).
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methodologies and to support research activities (e.g. extraction of data
for approved studies, peer review of cases with multiple anomalies).
All the procedures of the network, algorithms and analysis applied
to the data, data request/sharing rules with third parties are defined in
controlled documentation managed by the Central Registry. The
EUROCAT network operates at the highest level of interoperability
according to the classification reported by Tolk et al. (2006).
The processing of EUROCAT data by DG JRC follows the EU rules on
Data Protection (Regulation EC 45/2001), and in accordance with the
notification registered in the Register of the Data Protection Officer
(Notification DPO-3768.1, 2018).
3.3. Surveillance of congenital anomalies
The core activity of the Central Registry is to provide timely updates
of prevalence, prenatal diagnosis and perinatal mortality data, which
are published on the EUROCAT website (EUROCAT Prevalence Tables,
2018; EUROCAT Prenatal Detection Rates, 2018). The dynamic website
allows extracting tailored reports combining registries, years and
anomalies. Since 2015, after the transfer of the central database from
the University of Ulster, the JRC-EUROCAT Central Registry has man-
aged seven data submissions. This has increased the number of cases in
the database by 12%. Tables have been updated three times with pre-
valence rates for 92 congenital anomaly subgroups, giving detailed
information concerning the different pregnancy outcomes (livebirths,
Table 1
EUROCAT Full and Associate member registries: status, coverage and availability of data.
Country Registry Statusa Years of data available in
the Central Registry
Geographic area covered Country
coverage (%)b
Population typec
Austria Styria full 1985–2013 Province of Styria 13% Population-based I
Belgium Hainaut-Namur full 1980–2015 Provinces of Hainaut (East) and Namur 8% Population-based II
Antwerp full 1989–2015 Province of Antwerp 17% Population based III
Croatia Zagreb full 1983–2015 North-Western Croatia (Pula province, Rijeka
region, Varaždin province, Koprivnica province,
Vinkovci region)
12% Population-based I
Czech Republic Czech Republic associate 2000–2013 Czech Republic (national registry) 100% Population-based I
Denmark Odense full 1980–2012 Island of Funen with surrounding small islands 8% Population-based I
Finland Finland associate 1993–2013 Finland (national registry) 100% Population-based I
France Paris full 1981–2015 Greater Paris (Paris and its surrounding suburbs) 3% Population-based III
Auvergne full 2002, 2005–2012 Auvergne region including Allier, Cantal, Haute-
Loire and Puy-de-Dôme
2% Population-based II
Isle de Reunion full 2001–2015 Isle of Reunion 2% Population-based III
Rhone-Alps (REMERA) associate 2006–2014 Part of Rhone-Alpes region, including Rhône,
Loire, Isère, Savoie
7% Population-based II
French West Indies full 2009–2015 Martinique and Guadeloupe 1% Population-based III
Brittany full 2011–2015 Brittany (the whole region including 4
departments)
4% Population-based I
Germany Saxony Anhalt full 1980–2015 Federal State of Saxony-Anhalt 2% Population-based III
Mainz full 1990–2014 Mainz district and area of Rheinhesse 0,5% Population-based III
Hungary Hungary full 1998–2012 Hungary (national regsitry) 100% Population-based I
Ireland Dublin full 1980–2012 Counties of Dublin, Wicklow and Kildare 39% population-based I
Cork & Kerry full 1996–2015 Counties of Cork and Kerry 14% Population-based I
South East Ireland full 1997–2014 South East region of Ireland 11% Population-based I
Italy Tuscany full 1980–2015 Tuscany region 6% Population-based I
Emilia Romagna full 1981–2015 Emilia Romagna regiond 7% Population- based II
Malta Malta full 1986–2015 Malta (national registry) 100% Population- based I
Norway Norway full 1999–2012 Norway (national regsitry) 100% Population-based II
Poland Wielkopolska full 1999–2015 Wielkopolska region 10% Population‐based I
Polish Registry associate 1999–2011 Poland (national registry) 100% Population‐based I
Portugal South Portugal full 1990–2015 Regions of Algarve, Alentejo, and part of the Lisboa
e Vale do Tejo Region
25% Population-based I
Spain Basque Country full 1990–2014 Basque Country region 5% Population-based III
Hospital Network
(ECEMC)
associate 1980–2014 Data are obtained from about 70 hospitals
distributed all over Spain
more than 21% Population-based
Valencia Region full 2007–2015 Valencia Region 10% Population-based I
Sweden Sweden associate 2001–2003, 2007–2014 Sweden (national registry) 100% Population‐based I
Switzerland Vaud full 1989–2015 Canton of Vaud 10% Population-based I
Netherlands North Netherlands full 1981–2015 Provinces of Groningen, Friesland and Drenthe 9% Population-based I
Ukraine OMNI-Net full 2005–2015 Provinces of Rivne and Khmelnytsky 7% Population-based III
United Kingdom Wales full 1998–2015 Wales 4% Population based
Thames Valley full 1991–2015 Thames Valley region 4% Population-based I
Wessex full 1994–2015 Wessex region 4% Population-based I
East Midlands & South
Yorkshire
full 1998–2012 East Midlands & South Yorkshire regions 9% Population-based I
Northern England full 2000–2015 Northern England 4% Population-based I
South West England full 2005–2015 South West England 6% Population-based I
a Full registries provide unidentifiable case data; Associate members send aggregate data.
b Coverage is calculated on the total births in the area covered by the registry in the last year of data available in EUROCAT, based on EUROSTAT figures in the
same year for the country.
c Population-based: I = All mothers resident in defined geographic area.
II = All mothers delivering within defined geographic area, irrespective of place of residence.
III = All mothers delivering in defined geographic area excluding non-residents of that area.
Hospital-based: All mothers delivering in selected hospitals, irrespective of place of residence.
d The Emilia Romagna registry collects also cases from the Republic of San Marino.
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stillbirths and terminations of pregnancy for fetal anomaly) by each
Registry and by birth year from 1980.
Another important output of the Central Registry is the annual
statistical monitoring report, which includes: a) the analysis of clusters
identified for every anomaly subgroup in every registry over a 5-year
period, and b) 10-year Pan-European trends to detect/monitor any
significant variation in frequency of congenital anomalies at European
level. The most recent report for the birth years 2005–2014 was pre-
pared for the first time by the JRC-EUROCAT Central Registry and
published in January 2018 (Lanzoni et al., 2017).
Apart from routine data analysis, EUROCAT data are widely used
for various research studies. The wide use of EUROCAT data is highly
encouraged, and both EUROCAT members, as well as scientists not
associated with EUROCAT can request data following a well-defined
procedure (Requesting EUROCAT Data, 2018).
3.4. Governance structure
The DG JRC and the EUROCAT network member registries estab-
lished a legal framework – the Collaboration Agreement - for the
transfer and the continuation of EUROCAT European level coordinating
activities at the JRC in the context of the EU RD Platform. The
Collaboration Agreement, signed by the JRC and the individual re-
gistries, covers the objectives of the collaboration, roles and responsi-
bilities of the parties, governance and coordination, and protection of
the results of the collaboration. It establishes that registries remain the
owners of their data. For every use and publication of the data the
Central Registry requires formal approval from the registries.
The Collaboration Agreement foresees the joint JRC-EUROCAT
Management Committee, which coordinates the EUROCAT activities.
The roles of the Management Committee are to ensure the continued
scientific integrity of the EUROCAT database and any research arising
from it, decide on membership issues, supervise the security and con-
fidentiality of data held at the Central Registry including data trans-
mission. The Management Committee also supervises the organisation
of meetings, workshop and working groups, and takes decisions on
application for research studies, data release and authorship; finally it
approves the publication of the annual statistical monitoring report.
The JRC-EUROCAT Management Committee meets regularly 3–4 times
a year.
Another very important body is the EUROCAT Coding and
Classification Committee. The main aim of this committee is to improve
standardised coding and classification of congenital anomalies in
EUROCAT. The committee reviews the coding of congenital anomalies
and gives advice and guidance to all registries to ensure harmonization
of the data. It provides feedback to the registries via the JRC-EUROCAT
Central Registry. In addition, the Coding Committee examines cases
with multiple congenital anomalies, and reviews the cases included in
clusters and trends with feedback to local registries that are involved in
the statistical monitoring. An important task of the committee is to
regularly review EUROCAT subgroups for routine prevalence data and
to create validation routines with the Data Management Working Group
when needed.
4. Conclusions
The development of the EU RD Platform started with a compre-
hensive activity in order to secure a sustainable solution for the inter-
nationally recognised, long-lasting network of population-based re-
gistries for the surveillance of congenital anomalies in Europe,
EUROCAT. Overall, this process was not simply a ‘transfer’, but the
establishment of a whole new system, with new structures, which re-
quired a deep analysis of the processes with solutions for every legal
and technical, aspect involved. It was a challenging experience which
allows for continuing the work on the surveillance of congenital
anomalies in Europe in a new setting.
The JRC-EUROCAT Central Registry will disseminate the results of
the network's scientific activities to provide evidence to policy makers
and to facilitate linkage of EUROCAT data with other databases avail-
able at the JRC (e.g. environmental, socio-economic indicators).
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